Asia Healthcare Holdings expands its portfolio with AINU acquisition
AHH is investing Rs 600 crore through a combination of primary and secondary funding
Stay updated with breaking news from Laparoscopic Procedures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AHH is investing Rs 600 crore through a combination of primary and secondary funding
Share this article Share this article ResearchAndMarkets.com's offering. The global urology devices market is projected to reach USD 46,408.2 million by 2026 from USD 38,005.6 million in 2021, at a CAGR of 4.1%. Market growth is driven by factors such as the growing number of hospitals and investments in endoscopy and laparoscopy facilities, rising incidence and prevalence of urological conditions, and growing preference for minimally invasive procedures. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years. The ...
Medical devices company, TransEnterix (NYSEARCA:TRXC) is another small-cap growth stock that has sprung back to life in 2020. TRXC stock is up a whopping 1322% in the past six months. The company’s robotics platform will likely get significant traction this year, as regulatory approvals will support growth opportunities. The goal is for its “Senhance” robotics technology to gain widespread clinical adoption in the laparoscopic field. A few risks remain, though, and its inflated price limits TRXC stock’s attractiveness. Source: Shutterstock TransEnterix’s Senh...